INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) and Encourages Investors with Substantial Losses to Contact the Firm
Edelson Lechtzin LLPis investigating potential violations of the federal securities laws involving Arcturus Therapeutics Holdings Inc. (“Arcturus”) (NASDAQ: ARCT), resulting from allegations of providing potentially misleading business information to the investing public. https://mma.prnewswire.com/media/2457789/logo2_Logo.jpg If you have non-public information that could assist in the Arcturus Investigation or if you are an Arcturus investor who suffered a […]